期刊文献+

抗CD_(20)嵌合抗体Fab’片段在大肠杆菌中高效表达 被引量:7

High Expression of Chimeric Antibody Fab′Fragment Against CD_(20) in Ecoli
下载PDF
导出
摘要 利用PCR方法从抗CD2 0 ScFv表达载体上扩增重链可变区 (VH)、轻链可变区(VL)基因 ,然后将VH、VL 基因重组到Fab’表达载体中 ,构建成抗CD2 0 嵌合抗体Fab’片段表达载体 pYZFcd2 0 ,用pYZFcd2 0转化大肠杆菌 16C9,在 16C9菌中分泌表达可溶性抗CD2 0 Fab’片段 ,经分离纯化获得具有CD2 0 抗原特异结合活性的Fab’片段 ,竞争性免疫荧光抑制实验表明 ,抗CD2 0 Fab’片段能竞争性抑制亲本鼠源性抗CD2 0 单克隆抗体HI4 7和Daudi细胞CD2 0 The gene of the variable region of the heavy chain(V H) and light chain(V L) were amplified by PCR method from the expression vector of anti human CD 20 single chain Fv antibody fragment(ScFv),and then the expression vector (pYZFcd20)of chimeric antibody Fab' fragment against CD 20 was constructed by cloning V H,V L into the expression vector pYZF. The Fab' was expressed in Ecoli. The Fab' was purified by Protein G agarose. The competitive inhibition of immunofluorescence showed that the Fab' inhibited binding of the monoclonal antibody HI 47 to CD 20 on the surface of Daudi cell.
机构地区 中国医学科学院
出处 《高技术通讯》 EI CAS CSCD 2000年第4期9-12,共4页 Chinese High Technology Letters
基金 863计划资助项目!(863102090303)
关键词 单克隆抗体 抗体Fab' 大肠杆菌 Monoclonal antibody, Chimeric antibody Fab' fragment, CD_(20)
  • 相关文献

参考文献1

二级参考文献1

  • 1沈德诚,陈璋,于爱新,曹义海,白金芬,陈辉树,佘明,仲涛.一组抗胸腺细胞单克隆抗体的制备与鉴定(特异性分析)[J]中国免疫学杂志,1986(06). 被引量:1

共引文献17

同被引文献18

  • 1李扬秋,刘启发.血液肿瘤靶向治疗和免疫治疗[J].肿瘤防治研究,2004,31(6). 被引量:5
  • 2Golay .IT, Clark EA, Beverley PC, et d. The CD20 ( BP35 ) antigen is involved in activation of B cell from the G0 to the G1 phase of the cell cycle[J]. J Immunol, 1985, 135: 3795-3801. 被引量:1
  • 3Einfeld DA, Brown JP, Valentine MA, et al. Molecular cloning of the human B cell CD20 receptor predicts a hydrophoblc protein with multiple tramsmembrane domains[ J]. EMBO J, 1988, 7:711-717. 被引量:1
  • 4Liu AY, Robinson RJ, Murvay ED, et al. Production of a mouse-human chimeric monoclonal antibody to CD20 with potent Fc-dependent biologic activity[J]. J Immunol, 1987, 139: 3521-3526. 被引量:1
  • 5Press OW, Farr AG, Borroz KI, et al. Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies[J]. Cancer Res, 1989, 49: 4906-4912. 被引量:1
  • 6Preess OW, Howell-Clark J, Andereson S, et al. Retention of B-cell-specific monoclonal antibodies by human lymphoma cell[ J].Blood, 1994, 83: 1390-1397. 被引量:1
  • 7Leget GA, Czuczman MS. Use of rituximab, the new FDA-approved antibody[J]. Curr Opin Oncol, 1998, 10: 548-551. 被引量:1
  • 8Beiske H, Clark EA, Holte H, et al. Triggering of neoplastic B cells via surface IgM and the cell surface antigen CIY20 and CD40.Responses differ from normal blood B cells and are restricted to certain morphottogic subsets[J]. Int J Cancer, 1988, 42: 521-528. 被引量:1
  • 9ReffME, Carner K, Chambers KS, et al. Depletion of B cell in vivo by a chimeric mouse human monolona antibody to CD20[ J].Blood, 1994, 83: 435-445. 被引量:1
  • 10Einfeld DA;Brown JP;Valentine MA.Molecular cloning of the human B cell CD20 receptor predicts a hydrophobic protein with multiple transmembrane domains,1988(03). 被引量:1

引证文献7

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部